Byvalson (Allergan, Inc)
Welcome to the PulseAid listing for the Byvalson drug offered from Allergan, Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc |
| NON-PROPRIETARY NAME: | nebivolol hydrochloride and valsartan |
| SUBSTANCE NAME: | NEBIVOLOL HYDROCHLORIDE; VALSARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-06-03 |
| END MARKETING DATE: | 0000-00-00 |
Byvalson HUMAN PRESCRIPTION DRUG Details:
| Item Description | Byvalson from Allergan, Inc |
| LABELER NAME: | Allergan, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 80(mg/1; mg/1) |
| START MARKETING DATE: | 2016-06-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-5874_12f03cb0-1ed2-45e8-b432-2ef5dcf4faa7 |
| PRODUCT NDC: | 0023-5874 |
| APPLICATION NUMBER: | NDA206302 |
Other NEBIVOLOL HYDROCHLORIDE; VALSARTAN Pharmaceutical Manufacturers / Labelers:
